Clinical trial
Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant…
NCT00181948 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00181948 |
|---|---|
| Title | Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy |
| Official title | A Pilot Study of Strattera Treatment in Children With Attention-Deficit/Hyperactivity Disorder Who Have Poor Response to Stimulant Therapy |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | ADHD |
| Intervention type | Drug |
| Interventions | atomoxetine (Strattera) |
| Enrollment | 30 |
| Start date | Sep 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 22, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: